“…However, most proteins, including those involved in inflammatory pathways (CHI3L1, S100A8, S100A9, S100A11 and S100A12), neutrophil degranulation (ANXA3, FGL2, LRG1, PGLYRP1, DEFA1B and SLPI) and NETs (MPO and ELANE), were deficient in asymptomatic patients and increases progressively with disease severity. Notably, myeloid leukocyte activation and neutrophil degranulation pathways were enriched in these genes, further supporting the remarkable heterogeneity of neutrophils across different disease severity groups [21,28,50,60,61,150,[157][158][159][160].…”